Results 91 to 100 of about 145,860 (242)

Broadening horizons: Pathogenesis and therapeutics of renal ciliopathies

Journal of Cell Communication and Signaling, Volume 20, Issue 3, September 2026.
This review elucidates the molecular mechanisms and aberrant signaling pathways in renal ciliopathies, links genetic heterogeneity to clinical phenotypes, and lays a theoretical basis for prenatal diagnosis and novel therapies. Abstract Renal ciliopathies encompass a spectrum of genetic disorders arising from structural or functional impairments of ...
Qiaowei Zhang, Shuwen Xue, Zhi Gao, Panlai Shi, Li Wang, Qi Feng, Xiangdong Kong, Xiaofan Zhu   +7 more
wiley   +1 more source

Successful Dilation of Ileal Conduit Stenosis 47 Years After Construction: The Longest Reported Interval in the Literature

IJU Case Reports, Volume 9, Issue 5, September 2026.
ABSTRACT Introduction Ileal conduit diversion is commonly performed after cystectomy and is considered the gold standard. However, late complications can occur. Case Presentation A 74‐year‐old woman had undergone cystectomy with ileal conduit diversion for neurogenic bladder dysfunction 47 years earlier.
Ayaka Igarashi, Seiji Arai, Sho Watanuki, Yusaku Shimizu, Tatsuhiro Sawada, Akira Ohtsu, Yuji Fujizuka, Yoshitaka Sekine, Hidekazu Koike, Kazuhiro Suzuki   +9 more
wiley   +1 more source

A Case Report of Left Pyelonephritis With Low‐Grade Contralateral Vesicoureteral Reflux After Robot‐Assisted Right Nephroureterectomy

IJU Case Reports, Volume 9, Issue 5, September 2026.
ABSTRACT Introduction Pyelonephritis with contralateral vesicoureteral reflux (VUR) after robot‐assisted radical nephroureterectomy (RANU) in a solitary kidney has rarely been reported. Case Presentation A 73‐year‐old woman with preoperative lower urinary tract symptoms (LUTS; IPSS 15, OABSS 7) underwent right RANU for urothelial carcinoma of the renal
Shuhei Kusano, Shohei Tobu, Minika Yukimoto, Kyohei Matsushita, Akihiro Maeda, Yuka Kakinoki, Hiroaki Kakinoki, Maki Kawasaki, Mitsuru Noguchi   +8 more
wiley   +1 more source

Canadian Urological Association guideline: Diagnosis, management, and surveillance of neurogenic lower urinary tract dysfunction - Executive summary.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2019
Definitions/purpose The term “neurogenic bladder” describes lower urinary tract dysfunction that has occurred likely as a result of a neurological injury or disease.1 The International Continence Society (ICS) defines “neurogenic lower urinary tract ...
Alex G Kavanagh, R. Baverstock, L. Campeau, K. Carlson, Ashley Cox, D. Hickling, Genviève Nadeau, L. Stothers, B. Welk   +8 more
semanticscholar   +1 more source

Best practice in the assessment of bladder function in infants

Therapeutic Advances in Urology, 2014
The purpose of this article is to review normal developmental bladder physiology in infants and bladder dysfunction in conditions such as neurogenic bladder, posterior urethral valves and high grade vesicoureteric reflux.
Luis Guerra, Michael Leonard, Marco Castagnetti   +2 more
doaj   +1 more source

Urodynamic and Anamnestic Predictors for Individual Dose Adjustment of Intravesical Oxybutynin in Neurogenic Detrusor Overactivity: Results From the UPSIDE Study

Neurourology and Urodynamics, Volume 45, Issue 7, Page 1319-1327, September 2026.
ABSTRACT Introduction Intravesical oxybutynin (IVO) is a 2nd line treatment option for patients with neurogenic detrusor overactivity (NDO) who are not adequately managed by oral anticholinergics. The UPSIDE study aimed to identify urodynamic and anamnestic predictors for achieving a therapeutically satisfactory dose (TSD) of 1 mg/mL IVO and to ...
Arndt Van Ophoven, Severine Banek, Kristin Becker, Markus Heibel, Almut Hirsch, Margot Kieruj, Ines Kurze, Anja Lingnau, Barbara Ludwikowski, Tobias Luithle, Fabian Queissert, Wolfgang Rösch, Oliver Schindler, Regina Stredele, Thomas Michael Karl Völkl, Quentin Leidl, Michael Gedamke   +16 more
wiley   +1 more source

The Interpretability of the Neurogenic Bladder Symptom Score

Neurourology and Urodynamics, Volume 45, Issue 7, Page 1336-1342, September 2026.
ABSTRACT Objective To define mild, moderate and severe symptom categories of the neurogenic bladder symptom score (NBSS) and NBSS‐short form (SF), and to calculate the minimal clinically important difference (MCID) of the NBSS‐SF. Methods We used existing datasets from the original NBSS validation study (n = 230 patients with spinal cord injury (SCI ...
Jeremy Dai, Erica Li, Rose Khavari, Jorge Moreno‐Palacios, Cristiano M. Gomes, Jeremy Myers, John T. Stoffel, Sean Elliott, Sara M. Lenherr, Blayne Welk   +9 more
wiley   +1 more source

Robotic ileocystoplasty and bladder neck artificial urinary sphincter insertion: Video demonstration of technique

Urology Video Journal, 2019
Objective: To present our technique of combined robotic assisted clam ileocystoplasty and artificial bladder neck urinary sphincter (AUS) insertion to treat neurogenic urinary incontinence. Materials and methods: We present the case of a 38 year old male
Ashley Mehmi, Tamsin Drake, Hashim Hashim, Anthony Koupparis   +3 more
doaj   +1 more source

Prior Authorization for Sacral Nerve Stimulation in the Era of WISeR: Evaluation of U.S. Payer Coverage Policies

Neurourology and Urodynamics, Volume 45, Issue 7, Page 1280-1293, September 2026.
ABSTRACT Introduction Sacral nerve stimulation (SNS) is an established therapy for refractory urinary incontinence, yet the 2025 Wasteful and Inappropriate Service Reduction Model (WISeR) designated it as requiring mandatory prior authorization. No analysis has examined how U.S.
Thriaksh Rajan, Andre Revnew, David Sheyn, Adonis Hijaz, Ramy Abou Ghayda   +4 more
wiley   +1 more source

A Review of Botulinum Toxin A for the Treatment of Neurogenic Bladder

PM & R : the journal of injury, function, and rehabilitation, 2019
Prior to FDA approval of intradetrusor botulinum toxin (BoTA) injections for the treatment of neurogenic bladder, patients' treatment options were limited to use of pharmacotherapies such as antimuscarinics, alpha blockers, and more recently beta ...
L. F. Cooley, Stephanie J. Kielb
semanticscholar   +1 more source